Access to anti-retroviral drugs, female in Tajikistan
Tajikistan: Access to anti-retroviral drugs, female was 95.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Tajikistan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Tajikistan stood at 95.0%. That is the highest value across all 25 years on record.
The figure is up 8.0% on the previous year and up 352.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Tajikistan peaked at 95.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Tajikistan 19th out of 141 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Tajikistan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 3.0% | +50.0% |
| 2010 | 5.0% | +66.7% |
| 2011 | 8.0% | +60.0% |
| 2012 | 10.0% | +25.0% |
| 2013 | 13.0% | +30.0% |
| 2014 | 21.0% | +61.5% |
| 2015 | 31.0% | +47.6% |
| 2016 | 40.0% | +29.0% |
| 2017 | 48.0% | +20.0% |
| 2018 | 56.0% | +16.7% |
| 2019 | 66.0% | +17.9% |
| 2020 | 73.0% | +10.6% |
| 2021 | 78.0% | +6.8% |
| 2022 | 83.0% | +6.4% |
| 2023 | 88.0% | +6.0% |
| 2024 | 95.0% | +8.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 3.0% | 10 |
| 2010s | 29.8% | 5.0% | 66.0% | 10 |
| 2020s | 83.4% | 73.0% | 95.0% | 5 |
Countries ranked near Tajikistan
More gender data for Tajikistan
- Child population (UN estimates and projections) 3,892 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4634 % change on previous year (2030)
- Population 7,841 (2030)
- Working-age population (UN estimates and projections) 7,841 (2030)
- Population (UN estimates and projections), annual growth rate 2.7 % change on previous year (2030)
- Age population, age 00, female, interpolated 126,845 (2025)
- Age population, age 00, male, interpolated 134,134 (2025)
- Age population, age 01, female, interpolated 127,721 (2025)
- Age population, age 01, male, interpolated 134,916 (2025)
- Age population, age 02, female, interpolated 128,822 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Tajikistan?
- Access to anti-retroviral drugs, female in Tajikistan was 95.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Tajikistan?
- The highest recorded value was 95.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Tajikistan?
- The lowest recorded value was 0.0% in 2000.
- How does Tajikistan rank for access to anti-retroviral drugs, female?
- Tajikistan ranks 19th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Tajikistan?
- Over the last ten years it is up 352.4%. The long-run trend across the full record is volatile.
- Where does this Tajikistan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.